Matches in Wikidata for { <http://www.wikidata.org/entity/Q63319630> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q63319630 description "assaig clínic" @default.
- Q63319630 description "clinical trial" @default.
- Q63319630 description "clinical trial" @default.
- Q63319630 description "clinical trial" @default.
- Q63319630 description "clinical trial" @default.
- Q63319630 description "ensaio clínico" @default.
- Q63319630 description "ensayo clínico" @default.
- Q63319630 description "ensayu clínicu" @default.
- Q63319630 description "essai clinique" @default.
- Q63319630 description "klinisch onderzoek" @default.
- Q63319630 description "клінічне випробування" @default.
- Q63319630 description "կլինիկական փորձարկում" @default.
- Q63319630 description "临床试验" @default.
- Q63319630 name "Velcade (Bortezomib) Consolidation After Transplant" @default.
- Q63319630 type Item @default.
- Q63319630 label "Velcade (Bortezomib) Consolidation After Transplant" @default.
- Q63319630 prefLabel "Velcade (Bortezomib) Consolidation After Transplant" @default.
- Q63319630 P1050 Q63319630-B1C24F9A-C054-472F-A3FF-AFD68B65036C @default.
- Q63319630 P1132 Q63319630-D651FB6F-C3F4-49B6-9996-2F81F5738D92 @default.
- Q63319630 P1476 Q63319630-488AA7D1-B0F6-488D-A743-D3AA7894D076 @default.
- Q63319630 P17 Q63319630-03C90025-1E37-4704-8AC7-0E7E653DF4E8 @default.
- Q63319630 P1813 Q63319630-5A4053D5-A5D4-4ECA-8342-190502AE852B @default.
- Q63319630 P2899 Q63319630-18ADC1D2-11FD-4F0E-901B-34A67F68A1BF @default.
- Q63319630 P3098 Q63319630-D84F242E-5670-4DCA-B3FD-B358A06B7CC0 @default.
- Q63319630 P31 Q63319630-EB016C86-59A8-451E-BB4D-2898CEB66D2B @default.
- Q63319630 P4844 Q63319630-32038F92-FE7C-4A2B-B11B-5DB29B76009D @default.
- Q63319630 P4844 Q63319630-449D0984-9394-44EB-AF9E-981BF2B09A05 @default.
- Q63319630 P4844 Q63319630-5741B007-3622-4DC5-A3A9-E4047A697E64 @default.
- Q63319630 P4844 Q63319630-5B238893-5889-42C2-8A8E-B2542EA50517 @default.
- Q63319630 P4844 Q63319630-62123DF8-A3AD-47F7-9F38-4E5B30FF5123 @default.
- Q63319630 P4844 Q63319630-7097936E-3611-46DE-88AD-A7EDB710C3A8 @default.
- Q63319630 P4844 Q63319630-7C968D6E-74D1-45C1-96D4-92E0625F92DF @default.
- Q63319630 P4844 Q63319630-8FD6A770-F2B9-495B-9E5C-DB843B9A420E @default.
- Q63319630 P4844 Q63319630-A31E7C67-5005-4E2B-B5EB-2DCE3A4D257E @default.
- Q63319630 P4844 Q63319630-D0598ACE-4305-4C3F-B881-E1DA1BED858D @default.
- Q63319630 P4844 Q63319630-EAE1F719-9B5C-422A-B10F-4631946307F0 @default.
- Q63319630 P580 Q63319630-C71382B6-32F8-4AFD-8696-3A2254CB11AE @default.
- Q63319630 P582 Q63319630-65D8B62B-42A8-4D58-A2FA-2673F192ADF6 @default.
- Q63319630 P6099 Q63319630-A39DE46A-C22E-4A9B-BD12-D4A2E8C04280 @default.
- Q63319630 P8005 Q63319630-7D4EADB3-3E4A-430E-9B74-50FBD6B8C831 @default.
- Q63319630 P8363 Q63319630-60DEDB81-DD53-4E00-9AF3-123447D803D2 @default.
- Q63319630 P1050 Q467635 @default.
- Q63319630 P1132 "+256" @default.
- Q63319630 P1476 "An Open-label, Randomised Trial of Bortezomib Consolidation (With Thalidomide and Prednisolone) Vs Thalidomide and Prednisolone Alone in Previously Untreated Subjects With Multiple Myeloma After Receiving Bortezomib, Cyclophosphamide, Dexamethasone (VCD) Induction and Autologous Stem Cell Transplant" @default.
- Q63319630 P17 Q408 @default.
- Q63319630 P1813 "VCAT" @default.
- Q63319630 P2899 "+18" @default.
- Q63319630 P3098 "NCT01539083" @default.
- Q63319630 P31 Q30612 @default.
- Q63319630 P4844 Q11426176 @default.
- Q63319630 P4844 Q15889608 @default.
- Q63319630 P4844 Q203174 @default.
- Q63319630 P4844 Q27107351 @default.
- Q63319630 P4844 Q27108063 @default.
- Q63319630 P4844 Q27262132 @default.
- Q63319630 P4844 Q27266327 @default.
- Q63319630 P4844 Q27278862 @default.
- Q63319630 P4844 Q408524 @default.
- Q63319630 P4844 Q417222 @default.
- Q63319630 P4844 Q419319 @default.
- Q63319630 P580 "2012-01-13T00:00:00Z" @default.
- Q63319630 P582 "2015-12-30T00:00:00Z" @default.
- Q63319630 P6099 Q42824827 @default.
- Q63319630 P8005 Q76651189 @default.
- Q63319630 P8363 Q78089383 @default.